Talking about osteoarthritis is talking about the aging of joints. Or at least, that's how it has been so far and that's what ...

GNSC-001 is an investigational, adeno-associated virus gene therapy expressing an optimized form of IL-1Ra. The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 for ...

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee osteoarthritis-related pain in people with obesity, a trial finds.

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...

Dogs get arthritis for different reasons than humans, and the pain threatens the nature of our relationship with our pets.

Numerous private clinics claim to offer miraculous cures for hard-to-treat medical conditions, even though their treatments are not based on sound science.

“Among participants with obesity and knee osteoarthritis with moderate-to-severe pain, treatment with once-weekly injectable ...

Zoetis' strategic divestiture of non-core assets and strong market position in companion animal drugs support a robust growth ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.